Table 2—

Risk factors for 30-day all-cause mortality

NonsurvivorsSurvivorsOR (95%CI)p-value
Subjects n23295
Clinical characteristics
 Age >65 yrs22 (96)218 (74)7.8 (1.0–58.6)0.03
 Male10 (43)126 (43)1.0 (0.4–2.4)0.83
Risk factors for venous thromboembolism
 Cancer6 (26)42 (14)2.1 (0.8–5.7)0.21
 Surgery1 (4)26 (9)0.5 (0.1–3.6)0.66
 Immobility for ≥4 days7 (30)44 (15)2.5 (1.0–6.4)0.11
 Previous venous thromboembolism2 (9)35 (12)0.7 (0.2–3.1)0.92
Underlying diseases
 Chronic lung disease4 (17)49 (17)1.1 (0.3–3.2)0.77
 Congestive heart failure3 (13)42 (14)0.9 (0.3–3.2)0.86
Clinical presentation at admission
 Syncope2 (9)57 (19)0.4 (0.1–1.7)0.36
 Chest pain9 (39)161 (55)0.5 (0.2–1.3)0.20
 Dyspnoea17 (74)215 (73)1.0 (0.4–2.8)0.89
 Cardiac frequency ≥100 beats·min−19 (39)120 (41)0.9 (0.4–2.2)0.97
PO2 <60 mmHg14 (61)158 (54)1.3 (0.6–3.2)0.66
 Systolic blood pressure <120 mmHg14 (61)94 (32)3.3 (1.4–8.0)0.009
 PESI high-risk strata#22 (96)196 (66)11.1 (1.5–83.6)0.006
Electrocardiogram
 SI-QIII pattern0 (0)35 (12)0.16
 Complete/incomplete right bundle branch block1 (4)46 (16)0.2 (0–1.9)0.21
 Inverted T-waves in V1 through V33 (13)40 (14)1.0 (0.3–3.4)0.86
Laboratory findings
 cTnI >0.1 ng·mL−19 (39)93 (32)1.4 (0.6–3.3)0.65
  • Data are presented as n (%), unless otherwise stated. OR: odds ratio; CI: confidence interval; PO2: partial pressure of oxygen; PESI: pulmonary embolism severity index; cTnI: cardiac troponin I. #: strata defined in 17.